Results 151 to 160 of about 44,802 (314)

Resolution of long-standing persistent atrial fibrillation after coronary revascularization: a case report on this rare reversible cause of atrial fibrillation. [PDF]

Eur Heart J Case Rep
Sukumaran SK, Seena RA, Rangasamy S, Subbaraj SK, Brj K.   +4 more
europepmc   +1 more source

Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial.

Journal of the American College of Cardiology, 2003
L. Mitchell, J. Powell, A. Gillis, V. Kehl, A. Hallstrom   +4 more
semanticscholar   +1 more source

Understanding CPVT pathogenic mechanisms based on mutation location within RyR2: towards personalized medicine?

The Journal of Physiology, EarlyView.
Jean‐Pierre Benitah, Esther Zorio, Ana María Gómez   +2 more
wiley   +1 more source

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5767-5778, July 2026.
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström, Henrik Svanström, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Viktor Wintzell, Kristian Hveem, Christian Jonasson, Mads Melbye, Peter Ueda, Björn Pasternak   +10 more
wiley   +1 more source

Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review. [PDF]

Front Pharmacol
Spanakis M, Alexakis K, Ioannou P.
europepmc   +1 more source

Rate Versus Rhythm Control in a Multimorbid Patient With Tachy–Brady Syndrome: Evaluation of Clinical Outcomes and Pacing Dependency

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT This case report describes a 77‐year‐old man with multiple comorbidities, including atrial fibrillation, heart failure with mildly reduced ejection fraction, hypertension, diabetes mellitus, and prior coronary artery bypass grafting, who presented with severe hypertension and dyspnoea.
Reem Fakak, Emma Nordahl, Joseph Moutiris   +2 more
wiley   +1 more source

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study. [PDF]

Br J Clin Pharmacol
Meinert FM, Dimakos J, Cui Y, Filion KB, Renoux C, Douros A.   +5 more
europepmc   +1 more source

Beta Blocker Toxicity at Therapeutic Doses: A Look Into Carvedilol Use in the Elderly

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Beta‐blocker toxicity does not occur only in overdose situations. In vulnerable populations such as children and the elderly, therapeutic doses may produce cumulative toxic effects similar to those seen in acute overdose. These patients require monitoring that extends beyond basic laboratory investigations to preempt cumulative toxicity.
Samuel Amo‐Tachie
wiley   +1 more source

Antiarrhythmics in patients with out-of-hospital-cardiac arrest do not improve survival to hospital discharge

Journal of Evidence-Based Healthcare, 2020
Robert Allen, Peter Tepler, Ian deSouza
doaj   +1 more source

Cardiovascular adverse effects of common non-oncologic medications: from mechanisms to clinical management. [PDF]

Eur Heart J Cardiovasc Pharmacother
Bahit MC, Agudo-Quilez P, Zamorano J, Gibson CM.   +3 more
europepmc   +1 more source